A deep dive into the Fc–FcR axis as a therapeutic anchor in autoimmune disease, examining immune signaling and drug ...

Purpose of Study: The purpose of this study is to establish the safety and potential effectiveness of investigational FT819 in participants with moderate to severe systemic lupus erythematosus (SLE) ...

Autoimmune hepatitis responds well to long-term immunosuppression with low-dose glucocorticoids with added azathioprine or mycophenolate in approximately 80 to 90% of treated children. In children ...

While B-cell-targeted CAR T therapies have demonstrated strong efficacy in autoimmune diseases, their broader application is hindered by manufacturing complexity, safety concerns and prolonged immune ...

CD122 signaling plays a key role in the function of CD4, CD8 T cells and natural killer (NK) cells, as well as in the development and survival of tissue-resident memory T cells (TRMs). As a result, ...

Osaka, Japan – We all know that a strong immune system is a definite advantage. Yet, sometimes, the immune system goes awry and attacks one’s body. This autoimmunity is the cause of various disorders, ...

SEATTLE, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced it will prioritize ...

Century Therapeutics is hosting a live event to discuss details and data on promising preclinical cell therapy programs targeting autoimmune diseases and cancer, indicating transparency and engagement ...